Full-Time

Clinical Account Manager

Confirmed live in the last 24 hours

Cleerly

Cleerly

51-200 employees

AI platform for cardiovascular disease diagnosis

Compensation Overview

$105k - $130k/yr

+ Variable Compensation + Commission + Bonuses + Stock Options

Senior

Minneapolis, MN, USA

Field-based role covering MN, ND, SD, IA, NE, MO, and KS with frequent travel by car and plane.

Category
Customer Success
Sales & Account Management
Required Skills
Data Analysis
Requirements
  • You have a degree from an accredited college or university.
  • You bring 5+ years of cardiovascular-related experience, ideally in one of the following: Cardiovascular device or SaaS sales, Hospital-based clinical support (PA, NP, DNP, or RN), Cardiovascular pharmaceuticals or radiopharmaceuticals.
  • You are highly coachable, quick to learn complex medical concepts, and capable of communicating clinical value clearly.
  • You are relationship-driven and thrive in provider-facing environments.
  • You possess exceptional communication, presentation, and stakeholder management skills.
  • You are a self-starter with a high sense of urgency, accountability, and ethical integrity.
  • You’re experienced in navigating complex hospital environments and can tailor your strategy to a variety of stakeholders.
  • You’re agile in dynamic environments and energized by the opportunity to introduce innovative technology into the clinical workflow.
Responsibilities
  • Serve as the primary point of contact for clinical accounts, ensuring successful implementation and sustained adoption of Cleerly’s cardiovascular technology.
  • Deliver ongoing education and training to cardiologists, radiologists, and referring providers on Cleerly’s clinical value and product capabilities.
  • Develop and expand key account relationships with physicians, administrators, and other strategic stakeholders.
  • Identify growth opportunities within existing accounts through data analysis, provider feedback, and referral trends.
  • Partner cross-functionally with sales, implementation, and customer success to ensure seamless support for healthcare partners.
  • Support new product introductions and drive clinician awareness through peer education, onboarding, and in-service training.
  • Maintain accurate records and activity tracking in Salesforce.com.
  • Travel 50–80% within the assigned multi-state territory.

Cleerly Health uses artificial intelligence to analyze coronary computed tomography angiography (CCTA) imaging, helping healthcare providers detect atherosclerosis, or plaque buildup in arteries, at an earlier stage. The platform transforms complex imaging data into actionable insights, allowing for personalized treatment plans that improve patient outcomes and financial results for providers. Unlike traditional methods, Cleerly's approach provides a detailed evaluation of heart disease by characterizing and quantifying different types of plaque. The company's goal is to enhance cardiovascular care and improve heart health for patients.

Company Size

51-200

Company Stage

Series C

Total Funding

$417.8M

Headquarters

New York City, New York

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Cleerly raised $106M to scale growth and clinical evidence generation.
  • Partnership with Cardiac Care Alliance enhances cardiovascular care delivery.
  • Growing demand for AI-powered imaging solutions supports Cleerly's market expansion.

What critics are saying

  • Increased competition from AI-driven cardiovascular imaging companies could impact market share.
  • Reliance on partnerships may pose risks if collaborations don't meet expectations.
  • Regulatory challenges in AI healthcare could delay product rollouts and affect competitiveness.

What makes Cleerly unique

  • Cleerly integrates AI with coronary CT angiography for early atherosclerosis detection.
  • The company offers a digital care platform transforming imaging data into actionable insights.
  • Cleerly's AI technology enables precise plaque characterization beyond traditional heart disease measures.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, and vision plans

Stock Options

401(k) matching program

Company wide holidays

Self-managed PTO

Company News

Hit Consultant
May 6th, 2025
Ai Meets Value-Based Care: Cleerly And Cardiac Care Alliance Join Forces

AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces. by Jasmine Pennic 05/06/2025 Leave a Comment. What You Should Know: – Cleerly, a leader in cardiovascular imaging, and Cardiac Care Alliance, a prominent figure in value-based cardiovascular care solutions, today announced a strategic partnership aimed at significantly enhancing cardiovascular care delivery. – The collaboration will see the integration of Cleerly’s advanced AI-powered coronary artery assessment technology into Cardiac Care Alliance’s extensive cardiovascular care network. The initiative is set to launch initially with cardiology practices in Texas, with ambitions for broader implementation.Optimizing Cardiac Pathways with Advanced AI TechnologyA key objective of this partnership is to refine the diagnostic journey for patients with cardiovascular symptoms. Cardiac Care Alliance will incorporate Cleerly’s Artificial Intelligence–Quantitative Coronary Tomography (AI-QCT) technology into its offerings for payers and practices. The goal is to ensure that symptomatic patients, when appropriate, undergo Cleerly’s noninvasive assessment prior to considering cardiac catheterization procedures

Cleerly Health
May 6th, 2025
AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces to Revolutionize Heart Disease Detection

This collaboration will integrate Cleerly's advanced AI-powered coronary artery assessment technology with Cardiac Care Alliance's cardiovascular care network.

Women's Tabloid
Mar 28th, 2025
Cleerly reveals new insights on cardiovascular risk in women at ACC.25

Cleerly, a cardiovascular AI imaging company, has announced its participation in the American College of Cardiology Annual Scientific Session + Expo (ACC.25) to be held between March 29-31, 2025.

Cardiovascular Business
Mar 4th, 2025
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations

Denver-based Cleerly, known for using AI to evaluate coronary CT angiography (CCTA) images, has joined forces with San Francisco-based Bunkerhill Health, pioneers in AI-powered early detection software, to expand the reach of both companies' FDA-cleared solutions.

Times of Innovation
Dec 6th, 2024
AI Startup Cleerly Raises $106M for Heart Disease Detection

Cleerly's recent funding round was led by significant venture capital firms, including GGV Capital and RRE Ventures, among others, reflecting a growing investor interest in health tech solutions.